Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Understanding physician's knowledge and perception of chronic cough in Switzerland.
Curr Med Res Opin. 2022 Aug;38(8):1459-1466. doi: 10.1080/03007995.2022.2057154. Epub 2022 Apr 15.
Curr Med Res Opin. 2022.
PMID: 35369836
Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery.
Gountas I, Favre-Bulle A, Saxena K, Wilcock J, Collings H, Salomonsson S, Skroumpelos A, Sabale U.
Gountas I, et al. Among authors: favre bulle a.
Vaccines (Basel). 2023 Jan 25;11(2):258. doi: 10.3390/vaccines11020258.
Vaccines (Basel). 2023.
PMID: 36851136
Free PMC article.
Item in Clipboard
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.
Favre-Bulle A, Bencina G, Zhang S, Jiang R, Andritschke D, Bhadhuri A.
Favre-Bulle A, et al.
J Med Econ. 2023 Jan-Dec;26(1):283-292. doi: 10.1080/13696998.2023.2174748.
J Med Econ. 2023.
PMID: 36748342
Free article.
Item in Clipboard
Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland.
Owusu-Edusei K, Favre-Bulle A, Tsoumani E, Mutschler T, Cossrow N.
Owusu-Edusei K, et al. Among authors: favre bulle a.
Vaccine. 2024 May 10;42(13):3239-3246. doi: 10.1016/j.vaccine.2024.04.016. Epub 2024 Apr 11.
Vaccine. 2024.
PMID: 38609806
Free article.
Item in Clipboard
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland.
Favre-Bulle A, Huang M, Haiderali A, Bhadhuri A.
Favre-Bulle A, et al.
Pharmacoecon Open. 2024 Jan;8(1):91-101. doi: 10.1007/s41669-023-00445-8. Epub 2023 Nov 24.
Pharmacoecon Open. 2024.
PMID: 37999854
Free PMC article.
Item in Clipboard
Cite
Cite